This was corroborated by a recent study that observed that Adenosine (Ado), a purine nucleotide exerting anti-tumour activity in multiple human cancers, enhances RhoGDI2 expression in A2780 OV cancer cells and A2780 subcutaneous xenografts in nude mice. This evidence concerns the gene ARHGDIB and neoplasm.